Target intelligence / Profile preview

Lysine residue (K)

Target
K
Molecular classification
Other (amino acid side chain), Post-translational modification site
01

Overview

A lysine residue is an amino acid side chain present in proteins, distinguished by its ε-amino group. Lysine residues are essential for protein structure, stability, and function. They are the primary sites for diverse and biologically crucial post-translational modifications, such as acetylation, methylation, ubiquitination, and sumoylation, especially in the histone tails that regulate chromatin structure and gene expression. Lysines also frequently appear in enzyme active sites and play structural roles in binding and catalysis. Because they are ubiquitous and numerous in proteins, targeting specifically a lysine residue (as opposed to a distinct protein or receptor) is not usually considered a therapeutic strategy, although certain drugs are designed to covalently react with lysines at functional sites on specific proteins[1][6].

Other names
Lysε-amino group of lysineproteinogenic lysine
02

Mechanism of action

Covalent modification of lysine preventing functional protein interactions. Inhibition or enhancement of lysine post-translational modifications (e.g., acetylation, methylation) for epigenetic drugs.

03

Biological functions

Protein structure stabilization (via hydrogen bonding, salt bridges)Substrate for post-translational modifications (acetylation, methylation, ubiquitination)Regulation of protein function (e.g., enzyme active sites, DNA binding)Epigenetic regulation (histone modification)
04

Disease associations

Cancer (via dysregulation of lysine-modifying enzymes)Neurodegenerative disease (via protein modification defects)Metabolic disorders (when lysine catabolism is impaired)Inflammation (post-translational modification)
05

Safety considerations

Off-target effects due to ubiquity of lysine residues in human proteinsBroad impact on cell function from global modulation of lysine modifications
06

Interacting drugs

Covalent inhibitors targeting lysine (fragment electrophiles, e.g., certain kinase inhibitors)

1 more in the full profile.

07

Biomarkers

Modified lysine residues (acetyl-lysine, methyl-lysine) as biomarkers in histone or non-histone proteins in epigenetics

Beyond the preview

Go deeper on Lysine residue (K).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine residue (K).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call